{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:56:36Z","timestamp":1792133796977,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004935","name":"S\u00fcleyman Demirel \u00dcniversitesi","doi-asserted-by":"publisher","award":["4500-YL1-15"],"award-info":[{"award-number":["4500-YL1-15"]}],"id":[{"id":"10.13039\/501100004935","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suleyman Demirel University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Research on the tissue-protective effects of fluvoxamine (FLV), a selective serotonin reuptake inhibitor, rapidly expands. This study explores FLV\u2019s potential to protect against lipopolysaccharide (LPS)-induced neuroinflammation, a key factor in systemic inflammation-related neuronal damage. Four equal groups of thirty-two female Wistar Albino rats were created: FLV, LPS-FLV (50\u00a0mg\/kg intraperitoneal), LPS (5\u00a0mg\/kg intraperitoneal), and control. Both drugs were given in one dose on the same day. Tissues from the brain cortex, cerebellum, and hippocampus were taken for histopathology, immunohistochemistry, biochemistry, and genetic analysis. In the LPS group, histological examinations revealed hyperemia, edema, mild degeneration, neuronal death, and modest gliosis. Additionally, while apelin and total antioxidant status levels were reduced, greater levels of oxidative stress index, glial fibrillary acidic protein (GFAP), mammalian target of rapamycin (mTOR), and total oxidant status were noted. FLV treatment reversed all these findings. Genetic analyses revealed that LPS decreased sirtuin-1 (SIRT-1) and glutathione peroxidase 4 (GPX-4) while increasing high mobility group box protein 1 (HMGB-1). FLV treatment reversed all these parameters, and a significant result was obtained only with GPX-4. In this study, FLV treatment was shown to have anti-inflammatory and neuroprotective effects through various mechanisms on the brain cortex, cerebellum, and hippocampus tissues in addition to its antidepressant effects.<\/jats:p>","DOI":"10.1007\/s12035-025-04764-1","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T10:54:04Z","timestamp":1739616844000},"page":"7892-7902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Potential Ameliorating Effects of Fluvoxamine in a Rat Model of Endotoxin-Induced Neuroinflammation: Molecular Aspects Through SIRT-1\/GPX-4 and HMGB-1 Signaling"],"prefix":"10.1007","volume":"62","author":[{"given":"Muhammet Yusuf","family":"Tepeba\u015f\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"A\u015fc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar Aslan","family":"Ko\u015far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine Nur","family":"Din\u00e7er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma","family":"Sel\u00e7uk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6znur","family":"Kolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"H\u00fcseynov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"4764_CR1","doi-asserted-by":"publisher","first-page":"9999146","DOI":"10.1155\/2021\/9999146","volume":"2021","author":"R K\u00f6lliker-Frers","year":"2021","unstructured":"K\u00f6lliker-Frers R, Udovin L, Otero-Losada M et al (2021) Neuroinflammation: an integrating overview of reactive-neuroimmune cell interactions in health and disease. Mediators Inflamm 2021:9999146","journal-title":"Mediators Inflamm"},{"key":"4764_CR2","doi-asserted-by":"publisher","first-page":"1284214","DOI":"10.3389\/fnagi.2023.1284214","volume":"15","author":"Y Li","year":"2023","unstructured":"Li Y, Li Y-J, Zhu Z-Q (2023) To re-examine the intersection of microglial activation and neuroinflammation in neurodegenerative diseases from the perspective of pyroptosis. Front Aging Neurosci 15:1284214","journal-title":"Front Aging Neurosci"},{"key":"4764_CR3","doi-asserted-by":"publisher","first-page":"175628642311877","DOI":"10.1177\/17562864231187770","volume":"16","author":"K Melanis","year":"2023","unstructured":"Melanis K, Stefanou M-I, Themistoklis KM, Papasilekas T (2023) mTOR pathway\u2013a potential therapeutic target in stroke. Ther Adv Neurol Disord 16:17562864231187770","journal-title":"Ther Adv Neurol Disord"},{"key":"4764_CR4","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun S-C (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:1\u20139","journal-title":"Signal Transduct Target Ther"},{"key":"4764_CR5","doi-asserted-by":"crossref","unstructured":"Razick DI, Akhtar M, Wen J, et al (2023) The role of sirtuin 1 (SIRT1) in neurodegeneration. Cureus 15:6","DOI":"10.7759\/cureus.40463"},{"key":"4764_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1089\/ars.2017.7290","volume":"28","author":"CK Singh","year":"2018","unstructured":"Singh CK, Chhabra G, Ndiaye MA et al (2018) The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal 28:643\u2013661","journal-title":"Antioxid Redox Signal"},{"key":"4764_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KKW (2015) Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci 38:364\u2013374","journal-title":"Trends Neurosci"},{"key":"4764_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12967-023-04044-3","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Xu Y, Guo P et al (2023) CCL5\/CCR5-mediated peripheral inflammation exacerbates blood-brain barrier disruption after intracerebral hemorrhage in mice. J Transl Med 21:196","journal-title":"J Transl Med"},{"key":"4764_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fphar.2019.00395","volume":"10","author":"H Luo","year":"2019","unstructured":"Luo H, Xiang Y, Qu X et al (2019) Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer\u2019s disease through activation of BDNF-TrkB signaling pathway. Front Pharmacol 10:395","journal-title":"Front Pharmacol"},{"key":"4764_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4236\/jbbs.2017.72006","volume":"7","author":"SA Richard","year":"2017","unstructured":"Richard SA, Min W, Su Z, Xu H (2017) High mobility group box 1 and traumatic brain injury. J Behav Brain Sci 7:50\u201361","journal-title":"J Behav Brain Sci"},{"key":"4764_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fnins.2018.00628","volume":"12","author":"YN Paudel","year":"2018","unstructured":"Paudel YN, Shaikh MF, Chakraborti A et al (2018) HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction. Front Neurosci 12:628","journal-title":"Front Neurosci"},{"key":"4764_CR12","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D (2023) GPX4 in cell death, autophagy, and disease. Autophagy 19:2621\u20132638","journal-title":"Autophagy"},{"key":"4764_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbr.2016.08.005","volume":"316","author":"E Dall\u00e9","year":"2017","unstructured":"Dall\u00e9 E, Daniels WMU, Mabandla MV (2017) Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression. Behav Brain Res 316:189\u2013196","journal-title":"Behav Brain Res"},{"key":"4764_CR14","doi-asserted-by":"crossref","unstructured":"Cao Y, Chen J, Ren G, et al (2019) Punicalagin prevents inflammation in LPS-induced RAW264. 7 macrophages by inhibiting FoxO3a\/autophagy signaling pathway. Nutrients 11:2794","DOI":"10.3390\/nu11112794"},{"key":"4764_CR15","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1038\/s41598-017-04968-z","volume":"7","author":"M Ghareghani","year":"2017","unstructured":"Ghareghani M, Zibara K, Sadeghi H et al (2017) Fluvoxamine stimulates oligodendrogenesis of cultured neural stem cells and attenuates inflammation and demyelination in an animal model of multiple sclerosis. Sci Rep 7:4923","journal-title":"Sci Rep"},{"key":"4764_CR16","doi-asserted-by":"crossref","unstructured":"Ilhan I, Asci H, Tepebasi MY, et al (2022) Selenium exerts protective effects on inflammatory cardiovascular damage: molecular aspects via SIRT1\/p53 and Cyt-c\/Cas-3 pathways. Mol Biol Rep 1\u201311","DOI":"10.1007\/s11033-022-08192-5"},{"key":"4764_CR17","doi-asserted-by":"crossref","unstructured":"\u0130lhan \u0130, Asci H, Ozmen O, et al (2024) The renoprotective effects of cannabidiol on lipopolysaccharide-induced systemic inflammation model of rats. Naunyn Schmiedebergs Arch Pharmacol 1\u201311","DOI":"10.1007\/s00210-024-03391-2"},{"key":"4764_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ejn.14720","volume":"53","author":"R Troubat","year":"2021","unstructured":"Troubat R, Barone P, Leman S et al (2021) Neuroinflammation and depression: a review. Eur J Neurosci 53:151\u2013171","journal-title":"Eur J Neurosci"},{"key":"4764_CR19","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.3390\/ijms24054772","volume":"24","author":"L Dobrek","year":"2023","unstructured":"Dobrek L, G\u0142owacka K (2023) Depression and its phytopharmacotherapy\u2014a narrative review. Int J Mol Sci 24:4772","journal-title":"Int J Mol Sci"},{"key":"4764_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1570159X19666210517150418","volume":"20","author":"TB Jannini","year":"2022","unstructured":"Jannini TB, Lorenzo GD, Bianciardi E et al (2022) Off-label uses of selective serotonin reuptake inhibitors (SSRIs). Curr Neuropharmacol 20:693","journal-title":"Curr Neuropharmacol"},{"key":"4764_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2023.101114","volume":"72","author":"S Giatti","year":"2024","unstructured":"Giatti S, Diviccaro S, Cioffi L, Melcangi RC (2024) Post-Finasteride syndrome and post-Ssri sexual dysfunction: two clinical conditions apparently distant, but very close. Front Neuroendocrinol 72:101114","journal-title":"Front Neuroendocrinol"},{"key":"4764_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10787-020-00777-5","volume":"29","author":"V Dionisie","year":"2021","unstructured":"Dionisie V, Filip GA, Manea MC et al (2021) The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Inflammopharmacology 29:75\u201390","journal-title":"Inflammopharmacology"},{"key":"4764_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jagp.2023.06.001","volume":"31","author":"M Ly","year":"2023","unstructured":"Ly M, Gary ZY, Mian A et al (2023) Neuroinflammation: a modifiable pathway linking obesity, Alzheimer\u2019s disease, and depression. Am J Geriatr Psychiatry 31:853\u2013866","journal-title":"Am J Geriatr Psychiatry"},{"key":"4764_CR24","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1038\/s41380-022-01618-3","volume":"27","author":"H Matsuno","year":"2022","unstructured":"Matsuno H, Tsuchimine S, O\u2019Hashi K et al (2022) Association between vascular endothelial growth factor-mediated blood\u2013brain barrier dysfunction and stress-induced depression. Mol Psychiatry 27:3822\u20133832","journal-title":"Mol Psychiatry"},{"key":"4764_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1089\/neu.2021.0355","volume":"39","author":"M Shi","year":"2022","unstructured":"Shi M, Mi L, Li F et al (2022) Fluvoxamine confers neuroprotection via inhibiting infiltration of peripheral leukocytes and M1 polarization of microglia\/macrophages in a mouse model of traumatic brain injury. J Neurotrauma 39:1240\u20131261","journal-title":"J Neurotrauma"},{"key":"4764_CR26","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/hep.30761","volume":"70","author":"WE Rodriguez","year":"2019","unstructured":"Rodriguez WE, Wahlang B, Wang Y et al (2019) Phosphodiesterase 4 inhibition as a therapeutic target for alcoholic liver disease: from bedside to bench. Hepatology 70:1958\u20131971","journal-title":"Hepatology"},{"key":"4764_CR27","doi-asserted-by":"publisher","first-page":"1110775","DOI":"10.3389\/fimmu.2023.1110775","volume":"14","author":"X Min","year":"2023","unstructured":"Min X, Wang G, Cui Y et al (2023) Association between inflammatory cytokines and symptoms of major depressive disorder in adults. Front Immunol 14:1110775","journal-title":"Front Immunol"},{"key":"4764_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112719","volume":"148","author":"T Zhu","year":"2022","unstructured":"Zhu T, Wang L, Wang L, Wan Q (2022) Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: applications for natural compounds from medicinal herbs. Biomed Pharmacother 148:112719","journal-title":"Biomed Pharmacother"},{"key":"4764_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.acr.2022.04.001","volume":"155","author":"V Rao","year":"2022","unstructured":"Rao V, Bhushan R, Kumari P et al (2022) Chemobrain: a review on mechanistic insight, targets and treatments. Adv Cancer Res 155:29\u201376","journal-title":"Adv Cancer Res"},{"key":"4764_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-00955-0","volume":"8","author":"D Duarte Lobo","year":"2020","unstructured":"Duarte Lobo D, Nobre RJ, Oliveira Miranda C et al (2020) The blood-brain barrier is disrupted in Machado-Joseph disease\/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples. Acta Neuropathol Commun 8:1\u201319","journal-title":"Acta Neuropathol Commun"},{"key":"4764_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fphar.2020.00320","volume":"11","author":"S-Y Lv","year":"2020","unstructured":"Lv S-Y, Chen W-D, Wang Y-D (2020) The apelin\/APJ system in psychosis and neuropathy. Front Pharmacol 11:320","journal-title":"Front Pharmacol"},{"key":"4764_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s11033-022-08075-9","volume":"50","author":"A Li","year":"2023","unstructured":"Li A, Zhao Q, Chen L, Li Z (2023) Apelin\/APJ system: an emerging therapeutic target for neurological diseases. Mol Biol Rep 50:1639\u20131653","journal-title":"Mol Biol Rep"},{"key":"4764_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s43440-024-00587-4","volume":"76","author":"K Kami\u0144ska","year":"2024","unstructured":"Kami\u0144ska K, Borzuta H, Buczma K, Cudnoch-J\u0119drzejewska A (2024) Neuroprotective effect of apelin-13 and other apelin forms\u2014a review. Pharmacol Reports 76:439\u2013451","journal-title":"Pharmacol Reports"},{"key":"4764_CR34","doi-asserted-by":"crossref","unstructured":"Sen B, Gonultas S, Albayrak C, et al (2024) Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome. Korean J Obstet Gynecol","DOI":"10.5468\/ogs.24031"},{"key":"4764_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7150\/ijbs.52619","volume":"17","author":"Z Wang","year":"2021","unstructured":"Wang Z, Guo W, Yi F et al (2021) The regulatory effect of SIRT1 on extracellular microenvironment remodeling. Int J Biol Sci 17:89","journal-title":"Int J Biol Sci"},{"key":"4764_CR36","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1080\/10408398.2023.2170320","volume":"64","author":"GR Gandhi","year":"2024","unstructured":"Gandhi GR, Hillary VE, Antony PJ et al (2024) A systematic review on anti-diabetic plant essential oil compounds: dietary sources, effects, molecular mechanisms, and safety. Crit Rev Food Sci Nutr 64:6526\u20136545","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4764_CR37","doi-asserted-by":"publisher","first-page":"7988","DOI":"10.1039\/D4FO01354A","volume":"15","author":"I Romero-Herrera","year":"2024","unstructured":"Romero-Herrera I, Nogales F, del Carmen G-L\u00f3pez M et al (2024) Selenium supplementation via modulation of selenoproteins ameliorates binge drinking-induced oxidative, energetic, metabolic, and endocrine imbalance in adolescent rats\u2019 skeletal muscle. Food Funct 15:7988\u20138007","journal-title":"Food Funct"},{"key":"4764_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.986511","volume":"10","author":"L Wei","year":"2022","unstructured":"Wei L, Zhang W, Li Y, Zhai J (2022) The SIRT1-HMGB1 axis: therapeutic potential to ameliorate inflammatory responses and tumor occurrence. Front Cell Dev Biol 10:986511","journal-title":"Front Cell Dev Biol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04764-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04764-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:46:23Z","timestamp":1747194383000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04764-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4764"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04764-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Suleyman Demirel University local committee received ethical approval for animal studies (approval no. 26.01.2023\/ 01\u2013121). The Animal Research: Reporting in Vivo studies (ARRIVE) guidelines and protocol, version 2.0, were followed in conducting all of the studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}